Lilly Drug Company Website - Search News

News

Eli Lilly Has Its Next Billion-Dollar Weight Loss Drug

Health News Florida · 2d

Eli Lilly sues companies selling alternative versions of its weight loss drug

The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of its drug Zepbound.

Seeking Alpha · 6d

Eli Lilly: A New Leader In Weight Loss Drugs Is Clearly Emerging

Eli Lilly gains ground with Orforglipron’s success, showing growth potential and risks from momentum and tariffs. Read why LLY stock is a buy.

Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs

Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and weight-loss drugs, Mounjaro and Zepbound.

Houston Public Media2d

Eli Lilly sues Houston-based compounding pharmacy over alleged ‘knockoff’ obesity, diabetes drugs

Eli Lilly’s legal actions against Empower Pharmacy and other compounding pharmacies come several months after the FDA ...

6don MSN

Prediction: Eli Lilly's Newest GLP-1 Drug Will Be a Game-Changer for the Stock

Let's look at why this news could be a game-changer for Eli Lilly and its stock.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results